$MSTX...MSTX to Provide Updates on EPIC Study & 2015 Events
- Conference Call Scheduled for 8:00am ET / 5:00am PT on Tuesday January 6th, 2015
SAN DIEGO, Dec. 30, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, today announced that it will hold a conference call at 8am Eastern Time, 5am Pacific Time on Tuesday, January 6, 2015. The Company intends to provide an update on EPIC, its pivotal phase 3 study of its lead product candidate vepoloxamer (MST-188) in sickle cell disease, which the Company continues to expect will complete enrollment by the end of 2015, and anticipated clinical and business milestones for 2015.
